Loading...
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health records we sought to describe the association betwe...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425928/ https://ncbi.nlm.nih.gov/pubmed/32790733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0237693 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|